|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news of interest to hospital pharmacists, selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries; any comments regarding content of this publication should be emailed to CSHP. It should not be understood or inferred from the presence of advertisements that CSHP endorses any products or services advertised. Similarly, CSHP is not responsible for the quality of journalism reflected in the articles: it should not be understood or inferred that CSHP supports the information provided. MultiView and CSHP are not liable, any delays or inaccuracies in the information contained in this brief, nor for any actions taken or outcomes resulting from relying on the information provided herein.
In this issue:
• Responsibility falls to doctors to prescribe and dispense controversial abortion drug
• Fake oxycontin warning sounded in Kindersley, Sask. after 2 deaths
• Nosode homeopathic labels must read 'not vaccines or alternatives to vaccines'
• New oxycodone rules would give drug maker a monopoly in Canada
• A drug to treat Huntington's is closer than ever — but those who need it remain cautious
• The cannabis doctor is in
• Pharmacist saves life of woman stung by wasp
Responsibility falls to doctors to prescribe and dispense controversial abortion drug
Controversial abortion drug RU-486 might be coming to Canada, but whether you get your hands on it will be left up to a doctor.
Under Health Canada provisions for the "safe and effective use" of the drug, approved in the country recently, physicians will be left to both prescribe and dispense the product, under the name mifegymiso.
Fake oxycontin warning sounded in Kindersley, Sask. after 2 deaths
Recent drug overdoses in western Saskatchewan have police sounding an alarm over fake OxyContin. Kindersley RCMP say officers have dealt with three overdoses of young adults in the past month resulting in two deaths.
Fentanyl pills — counterfeit OxyContin — have recently been linked to several deaths in Western Canada including one last month in the Pleasantdale district of Saskatchewan.
Nosode homeopathic labels must read 'not vaccines or alternatives to vaccines'
Homeopathic products promoted to parents will need to be clear they are not vaccines or alternatives to vaccines, Health Canada says.
The department announced recently it is introducing label changes for certain homeopathic products.
Nosodes are ultradiluted forms of diseased tissue, pus, blood, or excretions from a sick person or animal that some homeopaths and naturopaths sell, often in a pellet form.
New oxycodone rules would give drug maker a monopoly in Canada
The Globe and Mail
The federal government's proposed rules aimed at making oxycodone more difficult to abuse would force generic versions of the popular drug off the market, handing the company at the centre of Canada's prescription painkiller crisis a monopoly.
Health Canada unveiled draft rules in June that would require slow-release oxycodone to be tamper-resistant, making it more difficult to crush, snort or inject for a quick high.
A unique online training program, developed by a team of experts and compliant with USP <797>, has just been launched by BCE Pharma. The program helps participants improve their knowledge and skills by watching videos related to compounding sterile preparations, filmed in a controlled environment. The participants also take part in online activities and quizzes to test their knowledge and answers are given in real time.
For more information call 1-514-544-5051 or visit www.bcepharma.com.
A drug to treat Huntington's is closer than ever — but those who need it remain cautious
The Globe and Mail
It has worked on mice and monkeys. And starting soon in Vancouver, scientists will begin a long-awaited trial to see if a new drug might also slow the progression of Huntington's disease in humans.
The Centre for Huntington Disease at the University of British Columbia, led by neurologist Dr. Blair Leavitt, is already in the process of identifying six patient candidates who in August will participate in a trial for a drug known as ASO-HTT, the first drug to target the cause of HD: a mutant gene that produces a toxic protein.
The cannabis doctor is in
Doctors can become subspecialists in fields such as cardiology,
gynecology or neurology, but
what about cannabinoidology? Just over
a year after new federal regulations
made physicians the gatekeepers for
prescribing access to medical marijuana, a handful are focusing on cannabis as a therapeutic agent and carving
out a new subspecialty.
Hospira's vision of integrity,
accountability, and speed
makes us a leading provider
of a comprehensive line of
high quality and cost
effective generic injectables
Learn more about Hospira's speciality injectable
pharmaceuticals at www.hospira.ca or contact
your Hospira Representative at 1-866-488-6088.
Pharmacist saves life of woman stung by wasp
A woman from the Laurentians is thanking her pharmacist for saving her life.
Josée Asselin was out working in her garden in Saint-Colomban a few weeks ago when she says she felt a sting on her arm. She glanced down and saw what looked like a wasp. In less than a minute, Asselin says she started itching all over. She jumped into the car to pick up an antihistamine at the pharmacy.
Missed last week's issue? See which articles your colleagues read most.
50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8